https://www.marketwatch.com/story/moderna-stock-falls-5-after-flu-vaccine-study-results-9826ada2
Moderna Inc. shares dove more than 5% in after-hours trading Thursday, after the company announced that a study into a flu vaccine candidate failed to reach...
Create an account or login to join the discussion